SP Elixir (OPC) Private Limited

Victoza (Liraglutide) 6mg/mL Injection is a medication used primarily for the management of type 2 diabetes and weight management. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by mimicking the action of the naturally occurring hormone GLP-1. This hormone helps regulate blood sugar levels by stimulating insulin release in response to meals, reducing the release of glucagon (which raises blood sugar), and slowing down gastric emptying, leading to feelings of fullness.

In addition to its role in diabetes management, Victoza is also approved for use in weight management in patients with obesity or those who are overweight and have related health conditions such as hypertension, type 2 diabetes, or dyslipidemia.

The injection is typically administered subcutaneously once daily, and the dosage may be adjusted based on the individual's response to treatment. Common side effects include nausea, vomiting, diarrhea, and potential risks of pancreatitis and kidney problems.

Regular monitoring of blood sugar levels, kidney function, and other health parameters is important while using this medication.